Table 1 Factors associated with pre-surgical adverse DOR in patients scheduled for laparoscopic cystectomy for endometriomas
Characteristics | Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|---|
Adverse DOR (n = 31) | Non-DOR (n = 112) | P value | OR (95%CI) | P value | |
Patient characteristics | |||||
Age (years) | 37.9 ± 4.1 (36.4–39.4) | 33.5 ± 4.9 (32.6–34.4) | <0.001 | 1.26 (1.11–1.43) | <0.001 |
Gravidity (%) | 0.5 ± 0.8 (0.2–0.7) | 0.2 ± 0.5 (0.1–0.2) | 0.02 | − | − |
Parity (%) | 0.4 ± 0.6 (0.1–0.6) | 0.1 ± 0.4 (0.03–0.2) | 0.02 | − | − |
Body mass index (kg/m2) | 22.0 ± 6.5 (19.6–24.4) | 21.4 ± 5.0 (20.5–22.4) | 0.64 | ||
Laterality of cysts | |||||
Unilateral (%) | 10 (32.3) | 64 (57.1) | 0.01 | − | − |
Bilateral (%) | 21 (67.7) | 48 (42.9) | |||
Total size of ovarian cyst (mm) | 83.1 ± 32.2 (71.3–94.9) | 73.1 ± 27.5 (67.9–78.2) | 0.09 | ||
Pre-surgical serum hormone concentrations | |||||
LH (mIU/mL) | 9.7 ± 9.9 (6.1–13.4) | 6.2 ± 8.4 (4.6–7.8) | 0.047 | − | − |
FSH (mIU/mL) | 10.3 ± 7.0 (7.7–12.8) | 6.5 ± 3.5 (5.8–7.1) | <0.001 | 1.16 (1.05–1.28) | 0.003 |
Estradiol (pg/mL) | 134.5 ± 167.1 (73.2–195.8) | 72.3 ± 87.2 (56.0–88.6) | 0.01 | − | − |
CA125 (U/mL) | 90.1 ± 104.7 (51.7–128.5) | 68.9 ± 53.0 (58.9–78.8) | 0.12 | ||